Live feed
Filing
SC 13G/A
SC 13G/A0001591986-20-000014·Aquilo Capital Management, LLC
Schedule 13G ownership disclosure
Spero Therapeutics Inc
Security class unavailable · CUSIP: 84833T103
Event date: 2020-09-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,719,870
- Percent of class
- 14.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001591986-20-000014
- Form type
- SC 13G/A
- Filer
- Aquilo Capital Management, LLC
- CIK
- CIK 1591986
- Filed
- Sep 23, 2020
- Reporting period
- Sep 11, 2020
- Description
- Schedule 13G beneficial ownership